Prenatal diagnosis of Huntington's disease (HD): experiences with six cases and PCR.
In the course of a 2-year predictive testing programme for Huntington's disease (HD), six couples from a total of 52 applicants requested prenatal testing. In each case, the pregnancy was in the first or second trimester when the couples were referred for DNA diagnosis. In five cases, exclusion testing was offered; in one case, a person at risk with an increased risk of being a gene carrier requested prenatal diagnosis. In all cases, informative markers for prenatal testing could be determined. Whenever possible, the newer technique of polymerase chain reaction (PCR) for D4S125 was applied to perform rapid prenatal diagnosis. Two couples withdrew before chorionic villus sampling was undertaken; prenatal diagnosis was completed in the remaining four cases. After exclusion testing, two pregnancies were determined to have an increased risk and two fetuses to have a low risk of being HD gene carriers.
Thies
U
U
Institute of Human Genetics, University of Göttingen, Germany.
Zühlke
C
C
Bockel
B
B
Schröder
K
K
D015139:Blotting, Southern; D015193:Chorionic Villi Sampling; D005260:Female; D005819:Genetic Markers; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis*; D010375:Pedigree; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D012306:Risk
D005819:Genetic Markers